ANSWER: Vaccines
Explanation:
The MoU signed under ‘Make in India’ initiative of Government of India will enable the Bharat Immunologicals and Biologicals Corporation Ltd (BIBCOL), a Central PSU under Department of Biotechnology, to develop Measles – Rubella vaccine at its plant at Chola, Bulandshahr, U.P.